Opana Er
Product Images NDC 21695-948

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Opana Er (NDC 21695-948). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (B639732f 8eb2 4592 Aca3 86faf7e5360b 01)

Chemical Structure (B639732f 8eb2 4592 Aca3 86faf7e5360b 01)
Chemical structure of the active ingredient in OPANA ER, showing a complex multi-ring molecule with hydroxyl, ketone, and methyl groups, along with a hydrochloride (HCl) component.*
FDA Label Image

Figure 1 (B639732f 8eb2 4592 Aca3 86faf7e5360b 02)

Figure 1 (B639732f 8eb2 4592 Aca3 86faf7e5360b 02)
A line graph comparing the percentage of patients improved versus percent of reduction or improvement in pain. The graph includes two lines: one for Oxymorphone ER and one for Placebo, showing higher improvement percentages with Oxymorphone ER at each level of pain reduction.*
FDA Label Image

Figure 2 (B639732f 8eb2 4592 Aca3 86faf7e5360b 03)

Figure 2 (B639732f 8eb2 4592 Aca3 86faf7e5360b 03)
A line graph comparing the percentage of patients improved at various percentages of pain reduction between Oxymorphone ER and placebo groups. The x-axis represents percent of pain reduction/improvement, and the y-axis shows the percentage of patients improved. Oxymorphone ER consistently shows higher patient improvement percentages across all pain reduction levels compared to placebo.*
FDA Label Image

Opana Er 5mg (B639732f 8eb2 4592 Aca3 86faf7e5360b 04)

Opana Er 5mg (B639732f 8eb2 4592 Aca3 86faf7e5360b 04)
Label for OPANA ER 5mg extended-release tablets containing Oxymorphone Hydrochloride. The label indicates a quantity of 60 tablets per bottle and includes information such as lot number, expiration date, and instructions for twice-a-day (every 12 hours) dosing. Packaged by Physician Partner, a division of Rebel Distributors Corp, with storage instructions at controlled room temperature 15°-30°C (59°-86°F). The label also displays Red and black text on a white background with peel tabs at each corner.*
FDA Label Image

Opana Er 10mg (B639732f 8eb2 4592 Aca3 86faf7e5360b 05)

Opana Er 10mg (B639732f 8eb2 4592 Aca3 86faf7e5360b 05)
The label for OPANA ER 10mg ER Tablets shows it is packaged by Physician Partner, a division of Rebel Distributors Corp. It includes information on controlled storage temperature and child safety. The tablets contain Oxymorphone Hydrochloride 10mg. The label design includes barcodes, lot, and expiration date fields and lists Novartis Consumer Health Inc. as the manufacturer.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.